Session 6
Pharmaceutical Applications

Programm

• 13:30 – 14:00 30 Min. 0 Min.

  • Plenary lecture

  The Emerging Role of Proteomics for Elucidating Target and Drug Mechanisms in Early Drug Discovery

  • Marcus Bantscheff (Heidelberg, DE)
• 14:00 – 14:20 15 Min. 5 Min.

  • Lecture

  Towards therapeutic drug monitoring and precision medicine – Mass spectrometric ITEM-ONE and ITEM-TWO analyses confirm and refine an assembled epitope of an anti-pertuzumab affimer

  • Michael O. Glocker (Rostock, DE)

   Pharmaceutical applications
• 14:20 – 14:40 15 Min. 5 Min.

  • Lecture

  Characterization of Proteoforms of mAbs by CE-MS – What are the respective contributions of CE and MS?

  • Christian Neusüß (Aalen, DE)

   Pharmaceutical applications
• 14:40 – 15:00 15 Min. 5 Min.

  • Lecture

  Targeting non-biological complex drugs: Complementary high-resolution mass spectrometric techniques for a detailed chemical description of complex active pharmaceutical ingredients

  • Lukas Schwalb (München, DE)

   Pharmaceutical applications